Skip to main content
Premium Trial:

Request an Annual Quote

Malaysian Company Buys $8M Stake in Synthetic Genomics

NEW YORK (GenomeWeb News) – Synthetic Genomics has sold one million shares to the Malaysian company Dragasic, a subsidiary of the Genting Group, for $8 million, Genting said today, according to the Malaysian news agency Bernama.
Genting said that the Class A common stock it purchased from Synthetic Genomics Founder, Chariman, and CEO Craig Venter represents a roughly two percent economic interest and three percent voting interest in the La Jolla, Calif.-based company.
Privately held Synthetic Genomics was founded in 2005.
In May, Synthetic Genomics and the Asiatic Centre for Genome Technology, which is also part of the Genting Group, announced that they had completed a first draft assembly and annotation of the oil palm genome.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.